A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system - PubMed (original) (raw)
A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system
J C Castelli et al. J Exp Med. 1997.
Abstract
The 2-5A system contributes to the antiviral effect of interferons through the synthesis of 2-5A and its activation of the ribonuclease, RNase L. RNase L degrades viral and cellular RNA after activation by unique, 2'-5' phosphodiester-linked, oligoadenylates [2-5A, (pp)p5' A2'(P5'A2')]n, n >=2. Because both the 2-5A system and apoptosis can serve as viral defense mechanisms and RNA degradation occurs during both processes, we investigated the potential role of RNase L in apoptosis. Overexpression of human RNase L by an inducible promoter in NIH3T3 fibroblasts decreased cell viability and triggered apoptosis. Activation of endogenous RNase L, specifically with 2-5A or with dsRNA, induced apoptosis. Inhibition of RNase L with a dominant negative mutant suppressed poly (I).poly (C)-induced apoptosis in interferon-primed fibroblasts. Moreover, inhibition of RNase L suppressed apoptosis induced by poliovirus. Thus, increased RNase L levels induced apoptosis and inhibition of RNase L activity blocked viral-induced apoptosis. Apoptosis may be one of the antiviral mechanisms regulated by the 2-5A system.
Figures
Figure 1
Inducible expression of human RNase L in NIH3T3 cells. (A) Western blot analysis was performed for the detection of human RNase L expression in vector control 3T3/neo cells (lane 1) and in NIH3T3 cells transfected with a lac inducible vector containing the human RNase L gene (3T3/RNaseLS) incubated 24 h in the absence (lane 2) or in the presence (lane 3) of 3 mM IPTG. Western blot analysis was performed as previously described (25) using a 1:2,500 dilution of a monoclonal antibody specific for the human RNase L enzyme which did not detect the endogenous murine RNase L (lane 1). Proteins were detected using ECL reagents (Amersham, Arlington Heights, IL). An autoradiograph of a 1-min exposure is shown. RNA degradation after induction of RNase L. (B) 3T3/RNaseLS cells were incubated in the absence (lanes 1 and 2) and presence (lane 3) of 3 mM IPTG for 24 h then transfected with 1 μM of ppp5′(A2′p5′)2A (lanes 2 and 3) by calcium phosphate coprecipitation as previously described (12). (C) Northern blot analysis using an 18S rRNA probe is shown after incubation of cells in the absence (lane 2) and presence (lanes 1 and 3) of 3 mM IPTG for 24 h followed by transfection with 1 μM of ppp5′(A2′p5′)2A (lanes 2 and 3). Cellular RNA was isolated and electrophoresed as described in Materials and Methods).
Figure 1
Inducible expression of human RNase L in NIH3T3 cells. (A) Western blot analysis was performed for the detection of human RNase L expression in vector control 3T3/neo cells (lane 1) and in NIH3T3 cells transfected with a lac inducible vector containing the human RNase L gene (3T3/RNaseLS) incubated 24 h in the absence (lane 2) or in the presence (lane 3) of 3 mM IPTG. Western blot analysis was performed as previously described (25) using a 1:2,500 dilution of a monoclonal antibody specific for the human RNase L enzyme which did not detect the endogenous murine RNase L (lane 1). Proteins were detected using ECL reagents (Amersham, Arlington Heights, IL). An autoradiograph of a 1-min exposure is shown. RNA degradation after induction of RNase L. (B) 3T3/RNaseLS cells were incubated in the absence (lanes 1 and 2) and presence (lane 3) of 3 mM IPTG for 24 h then transfected with 1 μM of ppp5′(A2′p5′)2A (lanes 2 and 3) by calcium phosphate coprecipitation as previously described (12). (C) Northern blot analysis using an 18S rRNA probe is shown after incubation of cells in the absence (lane 2) and presence (lanes 1 and 3) of 3 mM IPTG for 24 h followed by transfection with 1 μM of ppp5′(A2′p5′)2A (lanes 2 and 3). Cellular RNA was isolated and electrophoresed as described in Materials and Methods).
Figure 2
Induction of RNase L expression decreased protein synthesis and cell viability. After IPTG treatment, cellular protein synthesis was determined in 3T3/neo cells (circles) and 3T3/RNaseLS cells (squares) and plotted as a percentage of untreated cells. The points are mean values from duplicates with the standard deviation shown.
Figure 3
RNase L overexpression caused DNA cleavage characteristic of apoptosis. 3T3/neo (A and C) and 3T3/RNaseLS (B and D) cells were incubated for 24 h in the absence (A and B) and presence (C and D) of 3 mM IPTG. Apoptotic cells were detected in situ by using T7 DNA polymerase with methyl green counterstaining. Experiments were performed in triplicate.
Figure 4
Apoptosis of interferon-treated fibroblasts after activation with dsRNA. In situ DNA end-labeling (A–C) and Hoechst dye no. 33342 staining (D–F) of L929 cells. (A and D) After 48 h incubation in interferon-α/β (1,000 U/ml) (Sigma Chemical Co., St. Louis, MO). (B and E) 24 h incubation in synthetic dsRNA poly (I)·(C) (25μg/ml). (C and F), 24 h preincubation in interferon-α/β followed by an additional 24 h in poly (I)·poly (C). Apoptotic cells were detected in situ by using terminal deoxynucleotidyl transferase with methyl green counterstaining. Cells were stained with Hoechst dye (0.1 mg/ml in PBS for 15 min) and photographed using fluorescence on an Axiovert microscope (Carl Zeiss, Inc., Thornwood, NY). Inhibition of RNase L protects fibroblasts against poly (I)·poly (C)–induced apoptosis. (G) L929 cells were transiently cotransfected with the GFP (green fluorescent protein) gene and either control vector (open circles) or the RNase LZB1 gene (closed squares) then incubated in interferon-α/β (1,000 U/ml) for 24 h. Cells were then treated with poly (I)·poly (C) (25 μg/ml) and green fluorescent cells were quantified as a measure of cell viability at each of the indicated time points. (25).
Figure 4
Apoptosis of interferon-treated fibroblasts after activation with dsRNA. In situ DNA end-labeling (A–C) and Hoechst dye no. 33342 staining (D–F) of L929 cells. (A and D) After 48 h incubation in interferon-α/β (1,000 U/ml) (Sigma Chemical Co., St. Louis, MO). (B and E) 24 h incubation in synthetic dsRNA poly (I)·(C) (25μg/ml). (C and F), 24 h preincubation in interferon-α/β followed by an additional 24 h in poly (I)·poly (C). Apoptotic cells were detected in situ by using terminal deoxynucleotidyl transferase with methyl green counterstaining. Cells were stained with Hoechst dye (0.1 mg/ml in PBS for 15 min) and photographed using fluorescence on an Axiovert microscope (Carl Zeiss, Inc., Thornwood, NY). Inhibition of RNase L protects fibroblasts against poly (I)·poly (C)–induced apoptosis. (G) L929 cells were transiently cotransfected with the GFP (green fluorescent protein) gene and either control vector (open circles) or the RNase LZB1 gene (closed squares) then incubated in interferon-α/β (1,000 U/ml) for 24 h. Cells were then treated with poly (I)·poly (C) (25 μg/ml) and green fluorescent cells were quantified as a measure of cell viability at each of the indicated time points. (25).
Figure 5
Effect of Bcl-xL overexpression on apoptosis induced by dsRNA or poliovirus. After transient cotransfection of the GFP gene with control vector, (gray bars), RNase LZB1 (black bars), or Bcl-xL (hatched bars) genes, L929 cells were treated with (A) interferon-α/β (1,000 U/ml) and poly (I)·poly (C) (25 μg/ml) for 24 h and HeLa cells were treated with (B) poliovirus at 106 PFU for 45 h. Cell viability was assessed by quantitation of green fluorescent cells and presented as a percentage of untreated transfected cells. Experiments were performed in duplicate.
Figure 6
Inhibition of RNase L blocks poliovirus-induced apoptosis. HeLa cells were transiently cotransfected with GFP gene and either control vector (gray bars) or the RNase LZB1 gene (black bars). After incubation in 106 PFU type I poliovirus, GFP-positive cells were quantitated at each of the indicated time points. Cell numbers were calculated as a percentage of uninfected cells transfected with each of the vectors.
Similar articles
- The 2-5A system in viral infection and apoptosis.
Castelli J, Wood KA, Youle RJ. Castelli J, et al. Biomed Pharmacother. 1998;52(9):386-90. doi: 10.1016/s0753-3322(99)80006-7. Biomed Pharmacother. 1998. PMID: 9856285 Review. - The role of 2'-5' oligoadenylate-activated ribonuclease L in apoptosis.
Castelli JC, Hassel BA, Maran A, Paranjape J, Hewitt JA, Li XL, Hsu YT, Silverman RH, Youle RJ. Castelli JC, et al. Cell Death Differ. 1998 Apr;5(4):313-20. doi: 10.1038/sj.cdd.4400352. Cell Death Differ. 1998. PMID: 10200477 - The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation.
Player MR, Torrence PF. Player MR, et al. Pharmacol Ther. 1998 May;78(2):55-113. doi: 10.1016/s0163-7258(97)00167-8. Pharmacol Ther. 1998. PMID: 9623881 Free PMC article. Review. - Specificity and Mechanism of Coronavirus, Rotavirus, and Mammalian Two-Histidine Phosphoesterases That Antagonize Antiviral Innate Immunity.
Asthana A, Gaughan C, Dong B, Weiss SR, Silverman RH. Asthana A, et al. mBio. 2021 Aug 31;12(4):e0178121. doi: 10.1128/mBio.01781-21. Epub 2021 Aug 10. mBio. 2021. PMID: 34372695 Free PMC article. - A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L.
Malathi K, Paranjape JM, Bulanova E, Shim M, Guenther-Johnson JM, Faber PW, Eling TE, Williams BR, Silverman RH. Malathi K, et al. Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14533-8. doi: 10.1073/pnas.0507551102. Epub 2005 Oct 3. Proc Natl Acad Sci U S A. 2005. PMID: 16203993 Free PMC article.
Cited by
- Initiation of a ZAKα-dependent ribotoxic stress response by the innate immunity endoribonuclease RNase L.
Xi J, Snieckute G, Martínez JF, Arendrup FSW, Asthana A, Gaughan C, Lund AH, Bekker-Jensen S, Silverman RH. Xi J, et al. Cell Rep. 2024 Apr 23;43(4):113998. doi: 10.1016/j.celrep.2024.113998. Epub 2024 Mar 28. Cell Rep. 2024. PMID: 38551960 Free PMC article. - Complement Suppresses the Initial Type 1 Interferon Response to Ocular Herpes Simplex Virus Type 1 Infection in Mice.
Carr DJJ, Filiberti A, Gmyrek GB. Carr DJJ, et al. Pathogens. 2024 Jan 13;13(1):74. doi: 10.3390/pathogens13010074. Pathogens. 2024. PMID: 38251381 Free PMC article. - Early milk-feeding regimes in calves exert long-term effects on the development of ovarian granulosa cells.
Röttgen V, Tümmler LM, Koczan D, Rebl A, Kuhla B, Vanselow J, Baufeld A. Röttgen V, et al. BMC Genomics. 2023 Aug 25;24(1):485. doi: 10.1186/s12864-023-09589-7. BMC Genomics. 2023. PMID: 37626314 Free PMC article. - PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer.
Zhang B, Huang B, Zhang X, Li S, Zhu J, Chen X, Song H, Shang D. Zhang B, et al. Front Oncol. 2023 Jul 14;13:1217654. doi: 10.3389/fonc.2023.1217654. eCollection 2023. Front Oncol. 2023. PMID: 37519797 Free PMC article. - DNA methyltransferase inhibitor 5-azacytidine enhances neuroblastoma cell lysis by an oncolytic parainfluenza virus.
Kedarinath K, Shiffer EM, Parks GD. Kedarinath K, et al. Anticancer Drugs. 2023 Sep 1;34(8):916-928. doi: 10.1097/CAD.0000000000001525. Epub 2023 Apr 24. Anticancer Drugs. 2023. PMID: 37227036 Free PMC article.
References
- Clouston WM, Kerr JFR. Apoptosis, lymphotoxicity and the containment of viral infections. Med Hypotheses. 1985;18:399–404. - PubMed
- Clem RJ, Fechheimer M, Miller LK. Prevention of apoptosis by a baculovirus gene during infection of insect cells. Science (Wash DC) 1991;254:1388–1390. - PubMed
- Jacobsen H, Czarniecki CW, Krause D, Friedman RM, Silverman RH. Interferon-induced synthseis of 2-5A-dependent RNase in mouse JLS-V9R cells. Virology. 1983;125:496–501. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous